SUPERNUS PHARMACEUTICALS INC 4
4 · SUPERNUS PHARMACEUTICALS INC · Filed Feb 27, 2017
Insider Transaction Report
Form 4
Nuerge William A.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2017-02-24+7,905→ 7,905 totalExercise: $25.30From: 2018-02-24Exp: 2027-02-24→ Common Stock (7,905 underlying)
Holdings
- 23,750
Common Stock